Metabolism monitoring with microdialysis in the intensive care;Sledování metabolismu v intenzivní péãi pomocí mikrodialžy

Casopis Lekaru Ceskych

Volumn 150, Issue 11, 2011, Pages 605-609

  Burša, Filip ^a   Olos, Tomáš ^b   Pleva, Leopold ^c   Kula, Roman ^a   Jahoda, Jan ^a   Procházka, Václav ^d   Kopáček, Ivo ^c  

^a UNIVERSITY HOSPITAL OSTRAVA   (Czech Republic)

^b Resuscitační a Intenzivní Péče FN ^*  (Czech Republic)

^c Traumatologické Centrum FN Ostrava   (Czech Republic)

^d Ústav Radiodiagnostická FN   (Czech Republic)

Author keywords

Hemorrhagic shock; Lactate; Microdialysis; Muscle tissue

Indexed keywords

OXYGEN;

CHEMISTRY; EXTRACELLULAR FLUID; HEMORRHAGIC SHOCK; HUMAN; INTENSIVE CARE; METABOLISM; MICRODIALYSIS; MONITORING; REVIEW;

EXTRACELLULAR FLUID; HUMANS; INTENSIVE CARE; MICRODIALYSIS; MONITORING, PHYSIOLOGIC; OXYGEN; SHOCK, HEMORRHAGIC;

EID: 84555208160     PISSN: 00087335     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Waelgaard L, Thorgersen EB, Line PD, et. al. Microdialysis monitoring of liver grafts by metabolic parameters, cytokine production, and complement activation. Transplantation 2008;86(8):1096-1103.
2. Cibiček N, Živna H, Čermakova E, et. al. Sledování krevního prutoku v žaludku pomocí mikrodialýzy na potkaním modelu ischemie-reperfuze Klin Biochem Metab 2010;18(39):36-240.
3. Rostami E, Bellander BM. Monitoring of glucose in brain, adipose tissue, and peripheral blood in patients with traumatic brain injury: a microdialysis study. J Diabetes Sci Technol 2011;5(3):596-604.
4. Liu X, Kruger PS, Roberts MS. How to Measure Pharmacokinetics in Critically Ill Patients? Curr Pharm Biotechnol 2011; May 10 [Epub ahed of print].
5. Douglas A, Altukroni M, Udy AA, et. al. The pharmacokinetics of cefazolin in patients undergoing elective & semi-elective abdominal aortic aneurysm open repair surgery. BMC Anesthesiol 2011;11:5.
6. Simon F, Karlander, LE, et. al. Continous assessment of concentrations of cytokines in experimentak injurie sof the extremity. Exp Med 2009;2(4):354-362.
7. Roberts JA, Roberts MS, Semark A, et al. Antibiotic dosing in the 'at risk' critically ill patient: Linking pathophysiology with pharmacokinetics/ pharmacodynamics in sepsis and trauma patients. BMC Anesthesiol 2011;11:3.
8. Jansson L. et al. Postoperative on-line monitoring with intraperitoneal microdialysis is a sensitive clinical method for measuring increased anaerobic metabolism that correlates to the cytokine response. Scand 2004;39(5):434-439.
9. Widegren U, Hickner RC, Jorfeldt L, Henriksson J. Muscle blood flow response to mental stress and adrenaline infusion in man: microdialysis ethanol technique compared to (133) Xe clearance and venous occlusion plethysmography. Clin Physiol Funct Imaging 2010;30(2):152-161.
10. Farnebo S, Zettersten EK, Samuelsson A, Tesselaar E, Sjöberg F. Assessment of blood flow changes in human skin by microdialysis urea clearance. Microcirculation 2011;18(3):198-204.
11. Farnebo S, Samuelsson A, Henriksson J, et. al. Urea clearance: a new method to register local changes in blood flow in rat skeletal muscle based on microdialysis. Clin 2010;30(1):57-63.
12. Bruno L, Sébastien G, Patricia F, et al. Relation between muscle Na+K+ ATPase activity and raised lactate concentration in septic shock: a prospective study. The Lancet 2005;365:9462.
13. Ohashi S, et al. Utility of microdialysis to detect the lactate/pyruvateratio in subcutaneous tissue for the reliable monitoring of hemorrhagic shock. Res 2009;45(6):269-278.
14. Samuelsson A, Steinvall I, Sjoberg F. Microdialysis shows metabolit effects in skin during fluid resuscitation in burn-injured patiens. Crit Care 2006;10(6):R172.
15. Farnebo S, Zettersten A. Assessment of blood flow changes in human skin by microdialysis urea clearance. Microcirculation 2011;18(3):198-204.
16. Levy B, Desebbe O, Montemont C, et al. Increased aerobic glycolysis through beta2 stimulation is a common mechanism involved in lactate formation during shock states. Shock 2008;30(4):417-421.
17. Krejci V, Hiltebrand L, et al. Decreasing gut wall glucose as an early marker of impaired intestinal perfusion Critical Care Medicine 2006;34:2406-2414. (Pubitemid 44260027)
18. Allam Cl, Xu M, Mendendorp A. Determination of Renal Hypothermic Temperature Adequacy for Renoprotection During Ischemia Using Renal Interstitial Glycerol Concentrations in a Porcine Model Urology 2011;77(2):508.e1-4.
19. Solligård E, Jue IS, Bakkelund K, et al. Gut luminal microdialysis of glycerol as a marker of intestinal ischemic injury and recovery. Department of Anesthesiology and Intensive Care 2005;33(10):2278-2285. (Pubitemid 41437482)
20. Petriczko E, Horodnicka-Jozwa A, Grabowska-Wnuk W, et al. Interstitial measurements of glucose, glycerol and lactate in adolescents with decompensated type 1 diabetes. Neuro Endocrinol Lett 2010;31(4):559-567.
21. Trzeciak S, McCoy JV, Philip Dellinger R, et al. Early increases in microcirculatory perfusion during protocol-directed resuscitation are associated with reduced multi-organ failure at 24 h in patients with sepsis. Intensive Care Med 2008;34(12):2210-2217.
22. Adams RC, Lundy JS. Anesthesia in cases of poor surgical risk. Some suggestions for decreasing the risk. Surg Gynecol Obstet 1942;74:1011-1019.
23. Weiskopf RB, Viele MK, Feiner J, Kelley, et al. Human cardiovascular and metabolic response to acute, severe isovolemic anemia. JAMA 1998;279:217-221. (Pubitemid 28133784)
24. Lieberman JA, Weiskopf RB, Kelley SD, et al. Critical oxygen delivery in conscious humans is less than 7.3 mL O2 × kg (-1) × min (-1). Anesthesiology 2000;92:407-413. (Pubitemid 30078338)
25. Brimacombe J, Skippen P, Talbutt P. Acute anemia to a hemoglobin of 14 g/lwith survival. Anaesth Intensive Care 1991;19:581-583.
26. Hill SR, Carless PA, Henry DA, et al. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev 2002: CD002042.
27. Madjdpour C, Spahn DR, Weiskopf RB. Anemia and perioperative red blood cell transfusion: a matter of tolerance. Crit Care Med 2006;34: S102-108. (Pubitemid 43670475)
28. Walsh TS, Saleh EE. Anaemia during critical illness. Br J Anaesth 2006;97:278-291. (Pubitemid 44295662)
29. Hebert PC, Wells G, Blajchman MA, et. al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 1999;340:409-417. (Pubitemid 29084771)
30. Koch CG, Li L, Duncan AI, Mihaljevic T, et al. Transfusion in coronary artery bypass grafting is associated with reduced longterm survival. Ann Thorac Surg 2006;81:1650-1657. (Pubitemid 350030027)
31. Vincent JL, Baron J-F, Reinhart K, et al. Anemia and blood transfusion in critically ill patients. JAMA 2002;288:1499-1507.
32. Stainsby D, MacLennan S, Thomas, D et al. Guidelines on the management of massive blood loss. Br J Haematol 2006;135(5):634-641. (Pubitemid 44674073)
33. Sehgal LR, Zebala LP, Takagi I, et al. Evaluation of oxygen extraction ratio as a physiologic transfusion trigger in coronary artery bypass graft surgery patients. Transfusion 2001;41:591-595. (Pubitemid 32844997)
34. Vázquez BY, Hghtower CM, Martini J. Vasoactive hemoglobin solution improves survival in hemodilution followed by hemorrhagic shock. Crit Care Med 2011;39(6):1461-1466.
35. Boldt J, Ince C. The impact of fluid therapy on microcirculation and tissue oxygenation in hypovolemic patients: a review. Care Med 2010;36(8):1299-1308.
36. Samir M Fakhry, Fata P. How low is too low? Cardiac risks with anemia. Crit Care 2004;8(Suppl 2): S11-14. (Pubitemid 39144722)
37. Dubin A, Pozo MO, Ferrara G. Systemic and microcirculatory responses to progressive hemorrhage. Intensive Care Med 2009;35(3):556-564.